483 Nanjing Xingyin Pharmaceutical Group Aug 2017

483 Nanjing Xingyin Pharmaceutical Group Aug 2017

$119 - Not in Stock

FDA investigators audited the Nanjing Xingyin Pharmaceutical Group - Nanjing, China facility and issued inspectional observations (via FDA 483) on 31 Aug 2017.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Inspection end: 31 Aug 2017
  • Location: Nanjing, China
  • FEI: 3011942686

Pre-Order Not Available